In addition, in GIST with KIT T670I, cabozantinib can overcome imatinib resistance.69 As previously discussed, some resistance mutations may cause resistance to only one TKI and have little effect on other TKIs. This evidence concerns the gene KIT and gastrointestinal stromal tumor.